Increased norepinephrine‐associated adrenomedullary inclusions in Parkinson's disease
暂无分享,去创建一个
J. Goto | M. Kawamura | H. Ota | M. Sugie
[1] A. Atri,et al. Cavernous sinus syndrome and headache due to bilateral carotid artery aneurysms. , 2003, Archives of neurology.
[2] D. Goldstein,et al. Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension , 2003, Neurology.
[3] K. Wakabayashi,et al. Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy , 2002, Journal of neurology, neurosurgery, and psychiatry.
[4] K. Wakabayashi,et al. Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA , 2001, Neurology.
[5] L. Metman,et al. Cardiac Sympathetic Denervation in Parkinson Disease , 2000, Annals of Internal Medicine.
[6] S. Orimo,et al. 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.
[7] K. Iwanaga,et al. Lewy body–type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases , 1999, Neurology.
[8] T. Krause,et al. Impaired cardiac uptake of meta‐[123 I]iodobenzylguanidine in Parkinson's disease with autonomic failure , 1998, Acta neurologica Scandinavica.
[9] S. Hirai,et al. Decreased myocardial accumulation of 123I‐meta-iodobenzyl guanidine in Parkinson's disease , 1998, Nuclear medicine communications.
[10] D. Goldstein,et al. Sympathetic cardioneuropathy in dysautonomias. , 1997, Advances in pharmacology.
[11] Y. Koike,et al. A radiological analysis of heart sympathetic functions with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. , 1994, Journal of the autonomic nervous system.
[12] R. Coupland,et al. Morphological aspects of chromaffin tissue: the differential fixation of adrenaline and noradrenaline. , 1993, Journal of anatomy.
[13] T. Joh,et al. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease , 1990, Annals of neurology.
[14] R. Lloyd,et al. Immunohistochemical localization of epinephrine, norepinephrine, catecholamine-synthesizing enzymes, and chromogranin in neuroendocrine cells and tumors. , 1986, The American journal of pathology.
[15] F. Ikuta,et al. Tyrosine hydroxylase protein in Lewy bodies of parkinsonian and senile brains , 1984, Journal of the Neurological Sciences.
[16] P. Averback. TWO NEW LESIONS IN ALZHEIMER'S DISEASE , 1983, The Lancet.
[17] T. Hökfelt,et al. Immunohistochemical studies on monoamine-containing cell systems. , 1973, Brain research.
[18] T. Hökfelt,et al. Immunohistochemical studies on phenylethanolamine-N-methyltransferase, dopa-decarboxylase and dopamine-β-hydroxylase , 1971, Experientia.
[19] W. A. Jager,et al. Histochemistry of Adrenal Bodies in Parkinson's Disease , 1970 .
[20] W. A. Jager,et al. Sphingomyelin in Lewy inclusion bodies in Parkinson's disease. , 1969 .
[21] M. Hart,et al. Hyaline globules of the adrenal medulla. , 1968, American journal of clinical pathology.
[22] I. Benedeczky,et al. Various Cell Types of the Adrenal Medulla , 1964, Nature.
[23] R. Coupland,et al. A Method for Differentiating between Noradrenaline- and Adrenaline-storing Cells in the Light and Electron Microscope , 1964, Nature.
[24] J. Bethlem,et al. THE DISTRIBUTION OF LEWY BODIES IN THE CENTRAL AND AUTONOMIC NERVOUS SYSTEMS IN IDIOPATHIC PARALYSIS AGITANS , 1960, Journal of neurology, neurosurgery, and psychiatry.
[25] W. S. Monkhouse,et al. GRAY'S ANATOMY , 1947 .
[26] M. Utsuyama,et al. Element analysis of lewy and adrenal bodies in Parkinson's disease by electron probe microanalysis , 2004, Acta Neuropathologica.
[27] Hitoshi Takahashi,et al. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system , 2004, Acta Neuropathologica.
[28] A. Satoh,et al. [Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson's disease: assessment of cardiac sympathetic denervation]. , 1997, Nihon rinsho. Japanese journal of clinical medicine.
[29] 織茂智之. Cardiac ^ I-metaiodobenzylguanidine scintigraphy in patients with Parkinson disease , 1996 .
[30] W. A. den Jager. Histochemistry of adrenal bodies in Parkinson's disease. , 1970, Archives of neurology.
[31] W. A. den Jager. Sphingomyelin in Lewy inclusion bodies in Parkinson's disease. , 1969, Archives of neurology.
[32] N. Hillarp,et al. Evidence of adrenaline and noradrenaline in separate adrenal medullary cells. , 1953, Acta physiologica Scandinavica.